Search Results 331-340 of 16826 for GLP-1 agonists

  1. Impact Of RFA On Esophageal Distensibility And Mucosal Impedance - Mayo Clinic

    Receipt of glucagon-like peptide-1 agonists. Adults lacking the capacity to consent for self. Lack of English fluency. Note: Other protocol defined ...

  2. NSAIDs, on the other hand, block COX-1 and can cause side effects such as thinning of the stomach lining. This can lead to ulcers and bleeding. The risk of ...

  3. Drugs and Supplements - Mayo Clinic

    Look up information about prescription drugs, over-the-counter medications, herbs, vitamins and supplements.

  4. A Study of The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

    Clinical diagnosis, based on investigator assessment, of type 1 diabetes for at least one year and using insulin for at least 1 year. ... GLP-1 agonists ...

  5. Pasireotide s.c. in Patients with Post-Bariatric Hypoglycaemia - Mayo Clinic

    ... 1 trial. Phase 4 ... weeks prior to entering the run-in period. 11. Patients who have been treated with GLP-1 antagonists in the past must have a wash-out

  6. Type 1 Diabetes in a General Clinic Population

    The purpose of this study is to determine feasibility of establishing a T1D screening process for a general clinic population. Participation eligibility.

  7. A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... Antidiabetic treatment if glucagon-like peptide-1 receptor agonists (GLP1

  8. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of therapy ...

  9. Antidepressants: Selecting one that's right for you - Mayo Clinic

    Medicine options to treat depression include SSRIs, SNRIs, atypical antidepressants, tricyclic antidepressants, MAOIs and other drugs.

  10. A Comparative Effectiveness Study Of Major Glycemia-lowering Medications For Treatment Of Type 2 Diabetes - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.